{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:14:21Z","timestamp":1783448061399,"version":"3.55.0"},"reference-count":31,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":403,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In relapsing differentiated thyroid cancer (DTC), the in vivo evaluation of natrium\u2013iodide symporter (NIS) expression is pivotal in the therapeutic planning and is achieved by 131\/123Iodine (131\/123I) whole body scan. However, these approaches have low sensitivity due to the low resolution of SPECT. 18F-Tetrafluoroborate (TFB) has been proposed as a viable alternative, which could outperform 131\/123I scans owing to the superior PET resolution. We have reviewed the literature to collect the available data on TFB diagnostic performance and compare it with the standard methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Two authors searched PubMed, CENTRAL, Scopus, Web of Science and the web for studies evaluating the biodistribution and dosimetry of TFB in patients with DTC. General characteristics, technical parameters, procedures\u2019 sensitivities and standards of reference were extracted from the selected studies. The risk of bias was evaluated with the QUADAS-2 scoring system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five studies were included in the review. Two analysed TFB\u2019s biodistribution and dosimetry, while the other three assessed its diagnostic performance. The diagnostic comparators were 18F-FDG PET\/CT (all cases), 124I-PET\/CT (one study) and diagnostic\/therapeutic 131I-SPECT\/CT (one study each). TFB performed better than 131I; the TFB and 18F-FDG PET\/CT combination achieved the best sensitivity. TFB delivered significantly less dose than the other NIS tracers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>TFB is a promising tracer in relapsing DTC, showing higher sensitivity and less radiation exposure than the standard methods. The TFB and 18F-FDG combination appears particularly intriguing, especially when disease heterogeneity is suspected. However, data are still sparse and need to be confirmed by further investigations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/etj-24-0320","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T15:35:58Z","timestamp":1736523358000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":2,"title":["[18F]Tetrafluoroborate, a new NIS PET\/CT radiopharmaceutical: an overview focused on differentiated thyroid cancer"],"prefix":"10.1530","volume":"14","author":[{"given":"Arnoldo","family":"Piccardo","sequence":"first","affiliation":[{"name":"S.C. di Medicina Nucleare, Galliera Hospital 1 , ,","place":["Genoa, Italy"]},{"name":"Centro della Tiroide, \u201cGalliera Hospital\u201d 2 , ,","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3932-1330","authenticated-orcid":true,"given":"Francesco","family":"Fiz","sequence":"additional","affiliation":[{"name":"S.C. di Medicina Nucleare, Galliera Hospital 1 , ,","place":["Genoa, Italy"]},{"name":"Centro della Tiroide, \u201cGalliera Hospital\u201d 2 , ,","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Righi","sequence":"additional","affiliation":[{"name":"S.S.D. Fisica Medica, Galliera Hospital 3 , ,","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Raffa","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, IRCCS Ospedale Policlinico San Martino 4 , ,","place":["Genova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Riondato","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, IRCCS Ospedale Policlinico San Martino 4 , ,","place":["Genova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Bottoni","sequence":"additional","affiliation":[{"name":"S.C. di Medicina Nucleare, Galliera Hospital 1 , ,","place":["Genoa, Italy"]},{"name":"Centro della Tiroide, \u201cGalliera Hospital\u201d 2 , ,","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bauckneht","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, IRCCS Ospedale Policlinico San Martino 4 , ,","place":["Genova, Italy"]},{"name":"Department of Health Sciences, University of Genoa 5 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Massollo","sequence":"additional","affiliation":[{"name":"S.C. di Medicina Nucleare, Galliera Hospital 1 , ,","place":["Genoa, Italy"]},{"name":"Centro della Tiroide, \u201cGalliera Hospital\u201d 2 , ,","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Rizzo","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Candiolo Cancer Institute, FPO-IRCCS 6 , ,","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad Shoushtari Zadeh","family":"Naseri","sequence":"additional","affiliation":[{"name":"S.C. di Medicina Nucleare, Galliera Hospital 1 , ,","place":["Genoa, Italy"]},{"name":"Centro della Tiroide, \u201cGalliera Hospital\u201d 2 , ,","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Trimboli","sequence":"additional","affiliation":[{"name":"Faculty of Biomedical Sciences, Universit\u00e0 della Svizzera Italiana (USI) 7 , ,","place":["Lugano, Switzerland"]},{"name":"Clinic for Endocrinology and Diabetology, Ente Ospedaliero Cantonale 8 , ,","place":["Bellinzona, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Treglia","sequence":"additional","affiliation":[{"name":"Faculty of Biomedical Sciences, Universit\u00e0 della Svizzera Italiana (USI) 7 , ,","place":["Lugano, Switzerland"]},{"name":"Clinic of Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale 9 , ,","place":["Bellinzona, Switzerland"]},{"name":"Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne 10 , ,","place":["Lausanne, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"2026070712535007500_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"2026070712535007500_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/thy.1997.7.273","article-title":"131I therapy for elevated thyroglobulin levels","volume":"7","author":"Schlumberger","year":"1997","journal-title":"Thyroid"},{"key":"2026070712535007500_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40336-013-0024-0","article-title":"131I whole-body scan or 18FDG PET\/CT for patients with elevated thyroglobulin and negative ultrasound?","volume":"1","author":"Treglia","year":"2013","journal-title":"Clin Transl Imaging"},{"key":"2026070712535007500_bib4","first-page":"1164","article-title":"Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?","volume":"46","author":"Ma","year":"2005","journal-title":"J Nucl Med"},{"key":"2026070712535007500_bib5","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s00259-007-0660-6","article-title":"The diagnostic value of 124I-PET in patients with differentiated thyroid cancer","volume":"35","author":"Phan","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026070712535007500_bib6","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s00259-007-0634-8","article-title":"Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET\/CT and FDG-PET","volume":"35","author":"Freudenberg","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026070712535007500_bib7","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00259-007-0601-4","article-title":"Disseminated iodine-avid lung metastases in differentiated thyroid cancer: a challenge to 124I PET","volume":"35","author":"Freudenberg","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026070712535007500_bib8","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1089\/thy.2013.0713","article-title":"Do negative 124I pretherapy positron emission tomography scans in patients with elevated serum thyroglobulin levels predict negative 131I posttherapy scans?","volume":"24","author":"Khorjekar","year":"2014","journal-title":"Thyroid"},{"key":"2026070712535007500_bib9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0883-2889(92)90138-5","article-title":"The standardization and measurement of decay scheme data of 124I","volume":"43","author":"Woods","year":"1992","journal-title":"Appl Radiat Isot"},{"key":"2026070712535007500_bib10","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1007\/s00259-011-1782-4","article-title":"The production of [124I]iodine and [86Y]yttrium","volume":"38","author":"Schmitz","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026070712535007500_bib11","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.2967\/jnumed.117.192252","article-title":"18F-Tetrafluoroborate, a PET probe for imaging sodium\/iodide symporter expression: whole-body biodistribution, safety, and radiation dosimetry in thyroid cancer patients","volume":"58","author":"O\u2019Doherty","year":"2017","journal-title":"J Nucl Med"},{"key":"2026070712535007500_bib12","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.2017.19163","article-title":"Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement","volume":"319","author":"Mcinnes","year":"2018","journal-title":"JAMA"},{"key":"2026070712535007500_bib13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"Quadas-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"2026070712535007500_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13550-017-0337-5","article-title":"Safety, pharmacokinetics, metabolism and radiation dosimetry of 18F-tetrafluoroborate (18F-TFB) in healthy human subjects","volume":"7","author":"Jiang","year":"2017","journal-title":"EJNMMI Res"},{"key":"2026070712535007500_bib15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/RLU.0000000000001977","article-title":"Initial clinical investigation of [18F]tetrafluoroborate PET\/CT in comparison to [124I]iodine PET\/CT for imaging thyroid cancer","volume":"43","author":"Samnick","year":"2018","journal-title":"Clin Nucl Med"},{"key":"2026070712535007500_bib16","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s00259-020-04727-9","article-title":"Incremental diagnostic value of [18F]tetrafluoroborate PET-CT compared to [131I]iodine scintigraphy in recurrent differentiated thyroid cancer","volume":"47","author":"Dittmann","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026070712535007500_bib17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2967\/jnumed.123.266513","article-title":"Diagnostic performance of [18F]TFB PET\/CT compared with therapeutic activity [131I]iodine SPECT\/CT and [18F]FDG PET\/CT in recurrent differentiated thyroid carcinoma","volume":"65","author":"Ventura","year":"2024","journal-title":"J Nucl Med"},{"key":"2026070712535007500_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0146645314558019","article-title":"ICRP publication 128: radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances","volume":"44","author":"Mattsson","year":"2015","journal-title":"Ann ICRP"},{"key":"2026070712535007500_bib19","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41598-017-01044-4","article-title":"[18F]tetrafluoroborate-PET\/CT enables sensitive tumor and metastasis in vivo imaging in a sodium iodide symporter-expressing tumor model","volume":"7","author":"Diocou","year":"2017","journal-title":"Sci Rep"},{"key":"2026070712535007500_bib20","doi-asserted-by":"crossref","first-page":"2679260","DOI":"10.1155\/2022\/2679260","article-title":"Evaluation of [18F]tetrafluoroborate as a potential PET imaging agent in a sodium iodide symporter-transfected cell line A549 and endogenous NIS-expressing cell lines MKN45 and K1","volume":"2022","author":"Niu","year":"2022","journal-title":"Mol Imaging"},{"key":"2026070712535007500_bib21","doi-asserted-by":"crossref","DOI":"10.3791\/62334","article-title":"Dynamic imaging of chimeric antigen receptor T cells with [18F]tetrafluoroborate positron emission tomography\/computed tomography","author":"Sakemura","year":"2022","journal-title":"J Vis Exp"},{"key":"2026070712535007500_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13550-017-0280-5","article-title":"Tracking dendritic cell migration into lymph nodes by using a novel PET probe 18F-tetrafluoroborate for sodium\/iodide symporter","volume":"7","author":"Lee","year":"2017","journal-title":"EJNMMI Res"},{"key":"2026070712535007500_bib23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/1568009619666191016145602","article-title":"Uptake of [18F]tetrafluoroborate in MCF-7 breast cancer cells is induced after stimulation of the sodium iodide symporter","volume":"20","author":"Lehmacher","year":"2020","journal-title":"Curr Cancer Drug Targets"},{"key":"2026070712535007500_bib24","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s11307-024-01945-7","article-title":"Zirconium-89 labeled antibody K1-70 for PET imaging of thyroid-stimulating hormone receptor expression in thyroid cancer","volume":"26","author":"Parent","year":"2024","journal-title":"Mol Imaging Biol"},{"key":"2026070712535007500_bib25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.4158\/EP10065.CO","article-title":"Saul Hertz, MD (1905\u20131950): a pioneer in the use of radioactive iodine","volume":"16","author":"Hertz","year":"2010","journal-title":"Endocr Pract"},{"key":"2026070712535007500_bib26","doi-asserted-by":"crossref","first-page":"672094","DOI":"10.1155\/2014\/672094","article-title":"124 iodine: a longer-life positron emitter isotope-new opportunities in molecular imaging","volume":"2014","author":"Cascini","year":"2014","journal-title":"BioMed Res Int"},{"key":"2026070712535007500_bib27","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1021\/cr5001805","article-title":"Beyond the Balz-Schiemann reaction: the utility of tetrafluoroborates and boron trifluoride as nucleophilic fluoride sources","volume":"115","author":"Cresswell","year":"2015","journal-title":"Chem Rev"},{"key":"2026070712535007500_bib28","first-page":"71","article-title":"Impact of FDG PET on patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative 131I scan","volume":"42","author":"Schl\u00fcter","year":"2001","journal-title":"J Nucl Med"},{"key":"2026070712535007500_bib29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/thy.2018.0597","article-title":"Controversies, consensus, and collaboration in the use of 131I therapy in differentiated thyroid cancer: a joint statement from the American Thyroid Association, the European association of nuclear medicine, the society of nuclear medicine and molecular imaging, and the European Thyroid Association","volume":"29","author":"Tuttle","year":"2019","journal-title":"Thyroid"},{"key":"2026070712535007500_bib30","first-page":"61","article-title":"Is it iodine-refractory? The first post-therapeutic [131I]iodine and diagnostic [123I]iodine scans can underestimate the metastatic disease load in thyroid cancer: a case report","volume":"43","author":"Foppiani","year":"2024","journal-title":"Rev Esp Med Nucl Imagen Mol (Engl Ed)"},{"key":"2026070712535007500_bib31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/978-1-0716-3499-8_21","article-title":"Practical considerations for total-body PET acquisition and imaging","volume":"2729","author":"Spencer","year":"2024","journal-title":"Methods Mol Biol"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/etj.bioscientifica.com\/view\/journals\/etj\/14\/1\/ETJ-24-0320.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/14\/1\/ETJ-24-0320.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-24-0320\/32833\/etj-24-0320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-24-0320\/32833\/etj-24-0320.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:22:08Z","timestamp":1783444928000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/14\/1\/e240320\/4418\/18F-Tetrafluoroborate-a-new-NIS-PET-CT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.1530\/etj-24-0320","relation":{},"ISSN":["2235-0802","2235-0640"],"issn-type":[{"value":"2235-0802","type":"electronic"},{"value":"2235-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"article-number":"e240320"}}